Content

Zeneca Pharmaceuticals
Alderley Park, Macclesfield, Cheshire, UK

Phil Arundal (Zeneca, UK)
Use of Animal Data to Predict Kinetics in Man using Physiological Models
Chris Murray and Tim Auton (Proteus, UK)
Use of Bayesian Methods to improve the quality of an empirical scoring function for predicting binding energy
Martin Bayliss (Glaxo-Welcome, UK)
The Application of Multiple Compound (N in one) pharmacokinetic studies in modifying our approach to the drug discovery and lead optimisation process
Martin Brown (Institute of Speech and Intelligent Systems, Southampton University, UK)
Fuzzy and Neurofuzzy Method
Clair Ginn (Dept of Information Studies Sheffield University, UK)
The Application of Data Fusion to Similarity Searching of Chemical Databases
Mike Stubbins (Glaxo-Welcome, UK)
Genetic polymorphisms in human drug metabolising enzymes: The identification, verification and possible consequences of single nucleotide substitutions on enzymatic function and on disease susceptibility